Cargando…
Pharmacological Therapy in Inflammatory Bowel Diseases: A Narrative Review of the Past 90 Years
Inflammatory Bowel Diseases had their first peak in incidence in countries in North America, Europe, and Oceania and are currently experiencing a new acceleration in incidence, especially in Latin America and Asia. Despite technological advances, 90 years after the development of the first molecule...
Autores principales: | Imbrizi, Marcello, Magro, Fernando, Coy, Claudio Saddy Rodrigues |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537095/ https://www.ncbi.nlm.nih.gov/pubmed/37765080 http://dx.doi.org/10.3390/ph16091272 |
Ejemplares similares
-
Hypoalbuminemia as a risk factor for thromboembolic events in inflammatory bowel disease inpatients
por: Imbrizi, Marcello Rabello, et al.
Publicado: (2019) -
Changing paradigms in management of inflammatory bowel disease
por: Mao, Ren, et al.
Publicado: (2022) -
Pharmacologic therapy for inflammatory bowel disease refractory to steroids
por: Martínez-Montiel, MP, et al.
Publicado: (2015) -
Chios Mastic Gum: Chemical Profile and Pharmacological Properties in Inflammatory Bowel Disease: From the Past to the Future
por: Ottria, Roberta, et al.
Publicado: (2023) -
Inflammatory bowel disease: past, present, and future
por: Sands, Bruce E.
Publicado: (2007)